Anticancer activity of methyl-substituted oxaliplatin analogs.
Jungwirth U, Xanthos DN, Gojo J, Bytzek AK, Körner W, Heffeter P, Abramkin SA, Jakupec MA, Hartinger CG, Windberger U, Galanski M, Keppler BK, Berger W.
Jungwirth U, et al.
Mol Pharmacol. 2012 May;81(5):719-28. doi: 10.1124/mol.111.077321. Epub 2012 Feb 13.
Mol Pharmacol. 2012.
PMID: 22331606
Free PMC article.